Declage / Eutropin Plus, Eutropin | 2022

The drug profile includes the sales and forecast for the time period 2017 – 2028 for the United States and Rest of the World (ROW). It also covers the forecast summary and assumptions in terms of upsides and downsides.

Login to access report

launch Related Market Assessment Reports